Industry | 2021.08.05
Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease
Breakthrough Designation will advance the development of industry’s first predictive diagnostic device for conversion to Alzheimer’s disease, backed by two decades of global clinical studies
(PRWeb August 05, 2021)
Read the full story at https://www.prweb.com/releases/altoida_awarded_fda_breakthrough_designation_for_development_of_worlds_first_precision_neurology_device_for_prediction_of_alzheimer_s_disease/prweb18094062.htm
For more information, please visit
https://www.prweb.com/releases/altoida_a[...]er_s_disease/prweb18094062.htm
